Androgenic alopecia: an entity to consider in adolescence

Rodrigues, Marlene; Antunes, Inês; Magalhães, Sara; Pereira, Nélson

doi:10.1136/bcr-2017-220679

Cited by 6 publications

(3 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Prevalent in approximately 70% of men, androgenic alopecia is the loss of hair in the crown combined with an "M" shaped hairline recession. It also is seen in approximately 40% of women as diffuse thinning of hair [1]. Hair loss can have a considerable influence on psychological stress and quality of life.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Autologous Adipose Derived Stem Cell versus Platelet Rich Plasma Injection in the Treatment of Androgentic Alopecia: Efficacy, Side Effects and Safety

Kadry¹,

El-Kheir²,

Shalaby³

et al. 2018

J Clin Exp Dermatol Res

View full text Add to dashboard Cite

Background: Platelet Rich Plasma (PRP) is based on the release of growth factors stimulating the initiation/ extension of anagen phase as well as promoting vascularization, Adipose Derived Stem Cell (AT-ADSCs) treatment were recently introduced as an alternative potential therapeutic application for hair growth. Objective: The aim of this study was to assess the efficacy side effects and safety of AT-ASCs and PRP in the treatment of androgentic alopecia. Patients and methods: Sixty randomized patients were treated by PRP, and AT-ASCs. Each patient was evaluated, and each lesion was treated by those modalities, patients received three sessions with one month interval for 3 months, follow up after 3 months. Results: A highly significant improvement <0.001 in terminal hair count of AT-ASCs group evaluated by videodermoscopy assessment of AGA. That were confirmed by highly significant improvement in intermediate hair count and mean caliber (<0.001) associated with high incidence of side effects especially headache and erythema. In contrast, PRP group showed significant improvement 0.037 in terminal hair count and non-significant improvement in intermediate hair count and of mean caliber with minimum side effects. AT-ASCs showed a significant improvement in terminal hair count than PRP, Highly significant improvement in Intermediate hair count and hair caliber. Also, side effects of AT-ASCs showed highly significant pain, headache and erythema but no serious adverse events. Conclusion: Our study suggests that the There was significant improvement in AGA after PRP and highly significant after AT-ASCs therapy with significant difference of ADSC in terminal hair count and highly significant in caliber. Both modalities could effectively and safely be used to treat AGA.

show abstract

Section: Discussionmentioning

confidence: 99%

“…AGA is a skin disorder occurring in about 80% of men and 50% of women during their lifetime [1]. The Treatment of choice is still controversial which include medical treatments or surgical hair transplantation [2].…”

Section: Introductionmentioning

confidence: 99%

Autologous Adipose Derived Stem Cell versus Platelet Rich Plasma Injection in the Treatment of Androgentic Alopecia: Efficacy, Side Effects and Safety

Kadry¹,

El-Kheir²,

Shalaby³

et al. 2018

J Clin Exp Dermatol Res

View full text Add to dashboard Cite

show abstract

“…Androgenetic alopecia is the most common type of hair loss in both males and females and can occur at any age after puberty. [ 1 2 ] The severity of androgenetic alopecia progresses gradually with age; thus, the therapeutic goal is to prevent rapid progression or stop it entirely. [ 3 ] Since hair loss is an important aesthetic factor, it can seriously damage quality of life regardless of sex, age, and severity.…”

Section: Introductionmentioning

confidence: 99%

Assessment of Effects of Low-Level Light Therapy on Scalp Condition and Hair Growth

Kim,

Son,

et al. 2023

Indian Journal of Dermatology

View full text Add to dashboard Cite

Background: The appearance of the scalp and hair is very important aesthetically regardless of age or sex. Although there are many drugs and treatment methods for scalp problems and hair loss, the treatment response is still insufficient. Aims and Objectives: To evaluate the efficacy of low-level light therapy in a helmet-like device. Materials and Methods: This study was designed as a 24-week trial with 50 participants. All participants used a helmet-shaped device emitting 630–690, 820–880, and 910–970 nm light wavelengths, for 20 minutes, daily for 24 weeks. A phototrichogram for hair density and thickness, Global Aesthetic Improvement Scale score, erythema index, and sebum secretions of the scalp were evaluated at baseline and at 12 and 24 weeks. Results: After 24 weeks of treatment, hair density and hair thickness were found to have significantly increased ( P <.01 and P =0.013, respectively) and sebum secretion of vertex area had decreased significantly ( P <.01). Of 49 participants, 73.47% of the participants showed improvement in the overall appearance of the scalp ( n = 36). Conclusion: A helmet-like low-level light therapy device can improve the appearance of the hair, with thickening and increase in the density of the hair, and can improve scalp condition by decreasing sebum secretion.

show abstract

AGA/FPHL in Children and Adolescents

Anastassakis¹

2022

Androgenetic Alopecia From a to Z

View full text Add to dashboard Cite

Androgenic alopecia: an entity to consider in adolescence

Cited by 6 publications

References 2 publications

Autologous Adipose Derived Stem Cell versus Platelet Rich Plasma Injection in the Treatment of Androgentic Alopecia: Efficacy, Side Effects and Safety

Autologous Adipose Derived Stem Cell versus Platelet Rich Plasma Injection in the Treatment of Androgentic Alopecia: Efficacy, Side Effects and Safety

Assessment of Effects of Low-Level Light Therapy on Scalp Condition and Hair Growth

AGA/FPHL in Children and Adolescents

Contact Info

Product

Resources

About